NBC Securities’s Capricor Therapeutics CAPR Stock Holding History

NBC Securities’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$152K	Buy	+16,000	New	+$177K	0.01%	951

Other funds holding CAPR

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

Black Diamond Financial Towson, Maryland $1.18B AUM 15.24% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

VestGen Advisors Inverness, Illinois $3.25B AUM 30.95% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

NBC Securities's CAPR Position: Q3 2026 in Review

NBC Securities opened a new position in Capricor Therapeutics (CAPR) in Q3 2026: 16,000 shares worth $152K. The stake represents 0.01% of the portfolio and ranks #951 among its holdings.

25 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.

NBC Securities held 16,000 shares of Capricor Therapeutics worth $152K as of Q3 2026.
Capricor Therapeutics was a new NBC Securities position in Q3 2026.
Capricor Therapeutics made up 0.01% of NBC Securities's portfolio in Q3 2026, its #951 holding.
25 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.

Based on NBC Securities's 13F filing for Q3 2026, filed 26 Oct 2026.